Cargando…
Bazedoxifene for the prevention of postmenopausal osteoporosis
Bazedoxifene acetate is a novel, chemically distinct selective estrogen receptor modulator (SERM) that has been specifically developed after a stringent preclinical screening in order to obtain favorable effects on the skeleton and lipid metabolism with the additional improvement of a neutral effect...
Autores principales: | Gennari, Luigi, Merlotti, Daniela, De Paola, Vincenzo, Martini, Giuseppe, Nuti, Ranuccio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643104/ https://www.ncbi.nlm.nih.gov/pubmed/19337430 |
Ejemplares similares
-
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
por: Gennari, Luigi, et al.
Publicado: (2010) -
Lasofoxifene: Evidence of its therapeutic value in osteoporosis
por: Gennari, Luigi, et al.
Publicado: (2010) -
Current options for the treatment of Paget’s disease of the bone
por: Merlotti, Daniela, et al.
Publicado: (2009) -
Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2011) -
Incorporating bazedoxifene into the treatment paradigm for postmenopausal osteoporosis in Japan
por: Ohta, H., et al.
Publicado: (2014)